JEFFREY L WADE
CIK 1225767 · President and COO · last filed 2024-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$600.6K
Companies
2
Total Filings
39
Lifetime Open-Market Net
$60.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | President and COO | 312,792 | $1.92 | $600.6K | $60.8K | 38 | 2024-07-08 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Gen. Counsel | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings · Page 2 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-16 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2020-04-24 | LXRX | Mixed | +16,874 | -$18.9K | EDGAR |
| 2020-03-03 | LXRX | Mixed | +26,113 | -$44.4K | EDGAR |
| 2020-02-10 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2019-03-01 | LXRX | Mixed | +14,016 | -$47.6K | EDGAR |
| 2019-02-08 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2018-03-02 | LXRX | Mixed | +9,895 | -$52.3K | EDGAR |
| 2018-02-12 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2017-11-14 | LXRX | Buy (P) | +2,000 | $19.0K | EDGAR |
| 2017-03-01 | LXRX | Mixed | +9,204 | -$106.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.